BIO-TECHNE Corp — Investor Relations & Filings
Filings indexed
1,009
across all filing types
Latest filing
2026-05-06
Interim / Quarterly Rep…
Country
US
United States of America
Listing
US
TECH
Bio-Techne Corporation is a global developer, manufacturer, and supplier of high-quality reagents, analytical instruments, and services for the research and clinical diagnostic markets. The company's portfolio includes a wide range of life science tools such as recombinant proteins, antibodies, and immunoassays offered through its family of brands. Bio-Techne also provides automated platforms for protein characterization, including Simple Western and iCE systems, alongside next-generation Simple Plex assays. The company supports scientific discovery and accelerates the development of cell and gene therapies by delivering solutions focused on reproducibility and consistency, complemented by custom manufacturing and testing services.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q - BIO-TECHNE Corp (0000842023) (Filer) | 2026-05-06 | English | |
| 8-K - BIO-TECHNE Corp (0000842023) (Filer) | 2026-05-06 | English | |
| 4 - BIO-TECHNE CORP (0000842023) (Filer) | 2026-02-19 | English | |
| 8-K Filing | 2026-02-11 | English | |
| 4 Filing | 2026-02-05 | English | |
| 10-Q - BIO-TECHNE CORP (0000842023) (Filer) | 2026-02-04 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
8 filings
| |||||
| 42009437 | 10-Q - BIO-TECHNE Corp (0000842023) (Filer) | 2026-05-06 | English | ||
| 41797609 | 8-K - BIO-TECHNE Corp (0000842023) (Filer) | 2026-05-06 | English | ||
| 32882128 | 4 - BIO-TECHNE CORP (0000842023) (Filer) | 2026-02-19 | English | ||
| 24393799 | 8-K Filing | 2026-02-11 | English | ||
| 24393810 | 4 Filing | 2026-02-05 | English | ||
| 32882129 | 10-Q - BIO-TECHNE CORP (0000842023) (Filer) | 2026-02-04 | English | ||
| 24394049 | 8-K Filing | 2026-02-04 | English | ||
| 24393983 | 4 Filing | 2026-02-03 | English | ||
|
2025
7 filings
| |||||
| 9744506 | Major Shareholding Notification 2025 | 2025-11-14 | English | ||
| 9744507 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 2025-11-05 | English | ||
| 9744508 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 2025-11-05 | English | ||
| 9744509 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 2025-11-05 | English | ||
| 9744510 | 10-Q | 2025-11-05 | English | ||
| 9744511 | 8-K | 2025-11-05 | English | ||
| 9744512 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 2025-11-03 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Apellis Pharmaceuticals, Inc.
Biopharmaceutical company developing therapies by targeting…
|
APLS | US | Manufacturing |
|
Apeloa Pharmaceutical Co.,Ltd.
Integrated provider of APIs, CDMO services, and finished dr…
|
000739 | CN | Manufacturing |
|
ApicHope Pharmaceutical Group Co.,Ltd
Pharmaceutical firm focused on pediatric, chronic, and card…
|
300723 | CN | Manufacturing |
|
Apimeds Pharmaceuticals US, Inc.
Clinical-stage biopharma developing a bee venom drug and AI…
|
APUS | US | Manufacturing |
|
Apogee Therapeutics, Inc.
Clinical-stage biotech developing biologics for immunologic…
|
APGE | US | Manufacturing |
|
Apollomics Inc.
Clinical-stage biotech developing innovative oncology and c…
|
APLM | US | Manufacturing |
|
Apontis Pharma AG
Develops and markets fixed-dose combination drugs (Single P…
|
APPH | DE | Manufacturing |
|
Appili Therapeutics Inc.
Biopharmaceutical company developing novel medicines for in…
|
APLI | CA | Manufacturing |
|
Applied BioCode Corporation
Develops and manufactures high-throughput multiplex molecul…
|
6598 | TW | Manufacturing |
|
Applied Therapeutics, Inc.
Clinical-stage biopharma developing novel drugs for rare me…
|
APLT | US | Manufacturing |
BIO-TECHNE Corp via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/30718/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=30718 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=30718 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=30718 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 30718}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for BIO-TECHNE Corp (id: 30718)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.